Averna Therapeutics
PrivateLast Round
Series A
Jun 25, 2024
Total Funding Raised
$82M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Averna Therapeutics is a biotechnology company that develops RNA/lipid nanoparticle-based genomic medicines to durably and safely treat a broad range of diseases, including genetic disorders, cancer, and autoimmune conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Averna Therapeutics Comparables
Compare Averna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stylus Medicine | 81% | |
| Ensoma | 80% | |
| Tessera Therapeutics | 79% |
Averna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 25, 2024 |
Averna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Insight | Series A |
| Innovation Endeavors | Series A |
| OrbiMed | Series A, Seed |
| Invus Opportunities | Series A |
| Arc Ventures | Series A |
| Delos Capital Partners | Series A |
| Invus | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 28, 2.3x the trailing average.
- Jul 24, 2026
Monthly visitors increased 390% MoM, reaching 7.7K.
Averna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Averna Therapeutics's valuation, stock price, and market status.
Is Averna Therapeutics a public or private company?
Averna Therapeutics is a private company.
What is the current stock price of Averna Therapeutics?
Averna Therapeutics is a private company, so its shares have no public market price. Caplight tracks Averna Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Averna Therapeutics worth (valuation)?
Valuation information for Averna Therapeutics is not publicly available.
Can I buy Averna Therapeutics stock?
Averna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Averna Therapeutics's last funding round?
Averna Therapeutics's most recent funding round was Series A on June 25, 2024.
Who are the main investors in Averna Therapeutics?
Key investors in Averna Therapeutics include OrbiMed, Delos Capital Partners.
Will Averna Therapeutics IPO soon?
No public IPO plans have been announced for Averna Therapeutics.
How can I track Averna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Averna Therapeutics's shares on secondary markets.